Skip to content

Early Jejunostomy Nutrition Minimizes Time to Chemotherapy

Fast-track Surgery Recovery Program With Early Jejunostomy Nutrition Protocol Minimizes Time to Adjuvant Chemotherapy in Patients Undergoing Laparoscopic Gastrectomy for Gastric Cancer

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01766765
Enrollment
100
Registered
2013-01-11
Start date
2013-04-30
Completion date
2014-06-30
Last updated
2013-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy, Gastric Cancer, Laparoscopic Surgery

Brief summary

Adjuvant chemotherapy (AC) for gastric cancer is known to improve prognosis, and longer time to AC is associated with worse survival. However, most clinical trials mandate that AC is still to commence within 6 to 8 weeks after surgery consideration for malnutrition, postoperative complications and intolerance of AC. Placement of jejunostomy nutrition tube for enteral nutrition is a common component of these procedures, as a result of superior postoperative organ function, decreased infection rates, and a greater likelihood to complete AC with enteral nutritional support. Fast-track surgery (FTS) recovery program focuses on enhancing recovery and reducing morbidity. Introduction of FTS concepts are safe, feasible, and can achieve shorter hospital stays and reduced costs. Early postoperative enteral nutrition combined with FTS results in reductions in total complications compared with traditional postoperative feeding practices and does not negatively affect outcomes. However, the benefit of jejunostomy nutrition tube routine placement and combination with FTS is still being debated. Besides, there remains some controversy over the optimal combination of nutrients and duration and timing and routes of feed administration. The aim of this study was to determine whether FTS with early jejunostomy nutrition (EJN) following laparoscopic gastrectomy for gastric cancer improved postoperative recovery and minimizes time to AC when compared with FTS with early oral nutrition (EON).

Interventions

Free oral nutrition as tolerance allows on POD 1.

PROCEDUREJejunostomy

Routine placement of jejunostomy tube following laparoscopic gastrectomy for gastric cancer. Immediately drip 37°C saline 20 ml/h and exchange to drip 37°C enteral nutrition fluid 20 ml/h at postoperative 6 h via jejunostomy tube

Sponsors

National Natural Science Foundation of China
CollaboratorOTHER_GOV
Jinling Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Primary gastric cancer * R0 resection

Exclusion criteria

* Metastatic tumor * Locally unresectable tumor * Previous gastric/enteral resection * Age under 18 years or over 70 years * Preoperative complete parenteral or enteral nutrition * Neo-adjuvant chemotherapy * Severe malnutrition * Lack of the patient's consent for the trial participation, jejunostomy tube insertion or epidural analgesia

Design outcomes

Primary

MeasureTime frame
The time to the first adjuvant chemotherapy30 days after operation

Secondary

MeasureTime frame
Rehospitalization rate30 days after discharge
Energy metabolism10 days after operation
Overall morbidity rate of jejunostomy nutrition60 days after operation
Overall morbidity rate of early oral nutrition60 days after operation
Postoperative hospital stay length60 days after operation
Time to tolerate EJN/EON30 days after operation
Time to full oral nutrition30 days after operation
Body composition10 days after operation
Postoperative mortality rate60 days after operation

Countries

China

Contacts

Primary ContactQi Mao, MD/PhD
maoqimdphd@gmail.com+862580860961
Backup ContactYousheng Li, MD/PhD
liys@medmail.com.cn+862580860137

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026